Current Liabilities Cambiamento Data
Acadia Pharmaceuticals USD 254.25M 44.65M 2023-12
Alnylam Pharmaceuticals USD 967.79M 18M 2023-12
Amarin USD 266.69M 4.24M 2023-09
BioMarin Pharmaceutical USD 1.18B 13.8M 2023-12
Esperion Therapeutics USD 137.71M 30.54M 2023-09
Galectin Therapeutics USD 10.52M 569K 2023-09
Halozyme Therapeutics USD 112.49M 2.69M 2023-12
Incyte USD 1.24B 115.7M 2023-12
Insmed USD 225.63M 28.9M 2023-12
Ionis Pharmaceuticals USD 448.09M 43.88M 2023-12
Neurocrine Biosciences USD 691.6M 109.1M 2023-09
PTC Therapeutics USD 603.1M 110.98M 2023-12
Sarepta Therapeutics USD 450.74M 47.91M 2023-09
Ultragenyx Pharmaceutical USD 253.98M 9.6M 2023-09
United Therapeutics USD 804.4M 60.3M 2023-12



DBV Technologies Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.